BIOMARIN PHARMACEUTICAL INC (BMRN) Costs and Expenses USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Costs and Expenses for the quarter ending March 31, 2024 was $560 M, a 4.94% increase year-over-year.
  • Biomarin Pharmaceutical Inc Costs and Expenses for the twelve months ending March 31, 2024 was $2.29 B, a 9.01% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2023 was $2.26 B, a 16.2% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2022 was $1.95 B, a 0.93% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2021 was $1.93 B, a 1.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.29 B $560 M +$26.4 M +4.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.26 B $635 M +$73 M +13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $2.19 B $556 M +$47.9 M +9.44% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.14 B $536 M +$41.8 M +8.44% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $2.1 B $534 M +$152 M +39.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $1.95 B $562 M +$46.3 M +8.99% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $1.9 B $508 M +$45.8 M +9.91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.85 B $495 M +$4.63 M +0.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $1.85 B $382 M -$78.9 M -17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $1.93 B $516 M +$12.1 M +2.39% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $1.92 B $462 M -$70.8 M -13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $1.99 B $490 M +$19.6 M +4.16% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.97 B $461 M +$63.8 M +16.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $1.9 B $504 M +$40 M +8.63% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $1.86 B $533 M +$75.6 M +16.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $1.79 B $470 M +$41.3 M +9.63% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $1.75 B $397 M -$57.6 M -12.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $1.8 B $464 M +$72.2 M +18.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $1.73 B $457 M +$49.6 M +12.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.68 B $429 M +$31 M +7.79% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.65 B $455 M +$36.9 M +8.83% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $1.61 B $391 M +$91.1 M +30.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $1.52 B $407 M +$59.6 M +17.1% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $1.46 B $398 M +$41.8 M +11.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $1.42 B $418 M +$93.9 M +29% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $1.33 B $300 M -$89.5 M -23% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $1.42 B $348 M +$7.89 M +2.32% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $1.41 B $356 M -$517 M -59.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $1.93 B $324 M +$6.3 M +1.98% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $1.92 B $390 M +$263 M +208% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.66 B $340 M +$49.2 M +16.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $1.61 B $873 M +$559 M +178% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $1.05 B $318 M +$48.9 M +18.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $1 B $127 M -$162 M -56.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $1.16 B $291 M +$125 M +75.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $1.04 B $314 M +$104 M +49.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $933 M $269 M +$90.8 M +51% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $842 M $288 M +$89 M +44.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $753 M $165 M -$22.3 M -11.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $775 M $211 M +$53.8 M +34.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $722 M $178 M +$17.2 M +10.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $704 M $199 M +$20.3 M +11.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $684 M $188 M +$49 M +35.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $635 M $157 M +$1.89 M +1.22% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $633 M $161 M +$22.3 M +16.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $611 M $179 M +$49.6 M +38.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $561 M $139 M +$9.67 M +7.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $552 M $155 M +$45.1 M +41.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $507 M $139 M +$31.4 M +29.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $475 M $129 M +$24.3 M +23.2% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $451 M $129 M +$29.3 M +29.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $422 M $110 M +$21 M +23.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $401 M $107 M +$25 M +30.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $376 M $105 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $99.7 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $88.9 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $82.2 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.